It has been a difficult few months and during this time we at e-MFP have engaged with our members and friends to mobilize resources and adapt our activities to best mitigate the effects this pandemic brings to our sector and the vulnerable people we as a community serve.
One of our flagship activities is European Microfinance Week held annually in November and with it in mind, we have been closely monitoring the public health situation globally. Now more than ever it’s vital to connect and gather together the inclusive finance world to find solutions to the most pressing issues of the sector.
However in the face of the current situation with the Covid-19 pandemic we’ve taken the decision to gather responsibly and this year EMW 2020 will go online 16th – 20th November.
We are considering how this special edition online EMW 2020 might look like and how best to deliver the EMW goals of exchanging knowledge & connecting the financial inclusion sector and have reached out to our members for their input.
More information will be available soon!
The covid-19 pandemic has tested every country’s healthcare system, shining a light on the weaknesses in many and demonstrating areas of excellence in others. This coming November, during The Economist’s Future of Healthcare Week Asia, they will bring together healthcare leaders from across the Asia-Pacific region to take stock of lessons learnt and discuss what needs to be done to strengthen healthcare systems for the future.
Over the course of the week, policymakers, healthcare providers, academics and scientists will come together with representatives from industry, associations, charities and the finance sector to consider the issues that need to be overcome, and measures that need to be put in place, to build resilient healthcare systems that will withstand the test of time. Discussions will address matters including the long-term implications of covid-19, the digitisation of healthcare, vaccine development, data collection and interoperability, precision medicine, cancer care, antimicrobial resistance, healthy ageing, chronic diseases and new technologies.